Decision to implant a cardioverter defibrillator after myocardial infarction: The role of ejection fraction v. other risk factor markers

Medical Decision Making

Volumn 27, Issue 2, 2007, Pages 151-160

  Bailey, James J ^a   Hodges, Morrison ^b   Church, Timothy R ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

Arrhythmia; Implantable cardioverter defibrillator; Myocardial infarction; Risk stratification; Sudden cardiac death

Indexed keywords

ARTICLE; CONTROLLED STUDY; DEATH; DEFIBRILLATOR; DISEASE MARKER; HEART EJECTION FRACTION; HEART INFARCTION; HEART RATE VARIABILITY; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PROBABILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADRENERGIC BETA-ANTAGONISTS; ARRHYTHMIA; BAYES THEOREM; BIOLOGICAL MARKERS; DEFIBRILLATORS, IMPLANTABLE; HEART RATE; HUMANS; MULTICENTER STUDIES; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME;

EID: 34147213241     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X06297392     Document Type: Article

References (46)

1. Zipes DP, Wellens Hjj. Sudden cardiac death. Circulation. 1998 ; 98: 2334 - 51.
2. Moss AJ, Zareba W., Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002 ; 346: 877 - 83.
3. Reynolds MR, Josephson ME MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy. Circulation. 2003 ; 108: 1779 - 83.
4. FDA_7/18/2002. Summary of safety and effectiveness for guidant ICDs included in MADIT II [cited November 11, 2004]. Available from: http://www.fda.gov/cdrh/pdf/P910077S037b.pdf
5. Gregoratos G., Abrams J., Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation. 2002 ; 106: 2145 - 61.
6. CMS_9/28/2004. Proposed decision for implantable defibrillators (CAG-00157N2): II. Background, paragraph 2 and IV. Timeline of recent activities, item 6/6/2003. Available from: http://www.cms.hhs.gov/mcd/ viewdraftdecisionmemo.asp?id=139
7. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996 ; 335: 1933 - 40. 8. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999 ; 341: 1882 - 90.
8. Bardy G. SCD-HeFT: The Sudden Cardiac Death in Heart Failure Trial. ACC meeting. 2004. Available from: http://www.acc04online.org/ondemand/trials1/ sessions.asp?link=R
9. Bristow M., Feldman AM, Saxon LA Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators. J Card Fail. 2000 ; 6: 276 - 85.
10. Lee DS, Green LD, Liu PP, et al. Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. J Am Coll Cardiol. 2003 ; 41: 1573 - 82.
11. Ezekowitz JA, Armstrong PW, McAlister FA Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med. 2003 ; 138: 445 - 52.
12. Zareba W., Moss AJ Noninvasive risk stratification in postinfarctions patients with severe left ventricular dysfunction and methodology of the MADIT II noninvasive electrocardiology sub-study. J Electrocardiol. 2003 ; 36 (suppl): 101 - 8.
13. Josephson M., Wellens HJ Implantable defibrillators and sudden cardiac death. Circulation. 2004 ; 109: 2685 - 91.
14. Bailey JJ, Berson AS, Handelsman H., Hodges M. Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. J Am Coll Cardiol. 2001 ; 38: 1902 - 11.
15. Every NR, Hlatky MA, McDonald KM, Weaver WD, Hallstrom AP Estimating the proportion of post-myocardial infarction patients who may benefit from prophylactic implantable defibrillator placement from analysis of the CAST registry. Cardiac Arrhythmia Suppression Trial. Am J Cardiol. 1998 ; 82: 683 - 5, A8.
16. Huikuri HV, Tapanainen JM, Lindgren K., et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol. 2003 ; 42: 652 - 8.
17. Farrell TG, Bashir Y., Cripps T., et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol. 1991 ; 18: 687 - 97.
18. Gomes JA, Winters SL, Martinson M., Machac J., Stewart D., Targonski A. The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: a prospective study. J Am Coll Cardiol. 1989 ; 13: 377 - 84.
19. Hohnloser SH, Klingenheben T., Zabel M., Schopperl M., Mauss O. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. J Am Coll Cardiol. 1999 ; 33: 1895 - 902.
20. Honzikova N., Semrad B., Fiser B., Labrova R. Baroreflex sensitivity determined by spectral method and heart rate variability, and two-years mortality in patients after myocardial infarction. Physiol Res. 2000 ; 49: 643 - 50.
21. Ikeda T., Saito H., Tanno K., et al. T-wave alternans as a predictor for sudden cardiac death after myocardial infarction. Am J Cardiol. 2002 ; 89: 79 - 82.
22. Kostis JB, Byington R., Friedman LM, Goldstein S., Furberg C. Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction. J Am Coll Cardiol. 1987 ; 10: 231 - 42.
23. Kuchar DL, Thorburn CW, Sammel NL Prediction of serious arrhythmic events after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography. J Am Coll Cardiol. 1987 ; 9: 531 - 8.
24. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A., Schwartz PJ Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998 ; 351: 478 - 84.
25. Maggioni AP, Zuanetti G., Franzosi MG, et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI-2 results. Circulation. 1993 ; 87: 312 - 22.
26. Mukharji J., Rude RE, Poole WK, et al. Risk factors for sudden death after acute myocardial infarction: two-year follow-up. Am J Cardiol. 1984 ; 54: 31 - 6.
27. Pedretti R., Etro MD, Laporta A., Braga SS, Caru B. Prediction of late arrhythmic events after acute myocardial infarction from combined use of noninvasive prognostic variables and inducibility of sustained monomorphic ventricular tachycardia. Am J Cardiol. 1993 ; 71: 1131-41.
28. Rouleau JL, Talajic M., Sussex B., et al. Myocardial infarction patients in the 1990s-their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol. 1996 ; 27: 1119 - 27.
29. Ruberman W., Weinblatt E., Goldberg JD, Frank CW, Chaudhary BS, Shapiro S. Ventricular premature complexes and sudden death after myocardial infarction. Circulation. 1981 ; 64: 297 - 305.
30. Tapanainen JM, Still AM, Airaksinen KE, Huikuri HV Prognostic significance of risk stratifiers of mortality, including T wave alternans, after acute myocardial infarction: results of a prospective follow-up study. J Cardiovasc Electrophysiol. 2001 ; 12: 645 - 52.
31. Roche F., Dacosta A., Karnib I., et al. Arrhythmic risk stratification after myocardial infarction using ambulatory electrocardiography signal averaging. Pacing Clin Electrophysiol. 2002 ; 25: 791 - 8.
32. Steinbigler P., Haberl R., Bruggemann T., Andresen D., Steinbeck G. Postinfarction risk assessment for sudden cardiac death using late potential analysis of the digital Holter electrocardiogram. J Cardiovasc Electrophysiol. 2002 ; 13: 1227 - 32.
33. Tapanainen JM, Thomsen P., Kober L., et al. Fractal analysis of heart rate variability and mortality after an acute myocardial infarction. Am J Cardiol. 2002 ; 90: 347 - 52.
34. Farrell TG, Odemuyiwa O., Bashir Y., et al. Prognostic value of baroreflex sensitivity testing after acute myocardial infarction. Br Heart J. 1992 ; 67: 129 - 37.
35. Moses LE, Shapiro D., Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med. 1993 ; 12: 1293 - 1316.
36. Littenberg B., Moses LE Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making. 1993 ; 13: 313 - 21.
37. Niemal M., Airaksinen Kej, Huikuri HV Effect of beta-blockade on heart rate variability in patients with coronary artery disease. J Am Coll Cardiol. 1994 ; 23: 1370 - 7.
38. Andresen D., Bruggemann T., Behrens S., Ehlers C. Risk of ventricular arrhythmias in survivors of myocardial infarction. Pacing Clin Electrophysiol. 1997 ; 20 (10, pt 2). 2699 - 705.
39. Andresen D., Steinbeck G., Bruggemann T., et al. Risk stratification following myocardial infarction in the thrombolytic era: a two-step strategy using noninvasive and invasive methods. J Am Coll Cardiol. 1999 ; 33: 131 - 8.
40. Church TR Risk assessment and risk stratification in sudden cardiac death: a biostatistician's view. Pacing Clin Electrophysiol. 1997 ; 20 (10, pt 2). 2520 - 32.
41. Hodges M., Bailey JJ Ambulatory electrocardiography: use in arrhythmia risk assessment. In: Malik M, ed. Risk of Arrhythmia and Sudden Death. London: BMJ Books ; 2001. p 194 - 201.
42. Lown B., Calvert AF, Armington R., Ryan M. Monitoring for serious arrhythmias and high risk of sudden death. Circulation. 1975 ; 52 (6 suppl). I11189 - 98.
43. Anderson JL, Karagounis LA, Stein KM, Moreno FL, Ledingham R., Hallstrom A. Predictive value for future arrhythmic events of fractal dimension, a measure of time clustering of ventricular premature complexes, after myocardial infarction. CAST Investigators. Cardiac Arrhythmia Suppression Trial. J Am Coll Cardiol. 1997 ; 30: 226 - 32.
44. Reinhardt L., Mkijrvi M., Fetsch T., et al. Noninvasive risk modeling after myocardial infarction. Am J Cardiol. 1996 ; 78: 627 - 32.
45. Church TR, Hodges M., Bailey JJ, Mongin SJ Risk stratification applied to CAST registry data: combining 9 predictors. Cardiac Arrhythmia Suppression Trial. J Electrocardiol. 2002 ; 35 (suppl): 117 - 22.
46. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med. 1997 ; 337: 1569 - 75. 48. Bigger JT Expanding indications for implantable cardiac defibrillators. N Engl J Med. 2002 ; 346: 931 - 3.